Format

Send to

Choose Destination
Eur Heart J. 2019 Jul 1;40(25):2006-2017. doi: 10.1093/eurheartj/ehz300.

May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension.

Collaborators (301)

Burazeri G, Qirjako G, Roshi E, Cunashi R, Fernandes MJCC, Victória Pereira SS, Neto MFMP, Oliveira PNM, Feijão ACG, Cerniello Y, Marin MJ, Garcia Vasquez F, Espeche WG, Stisman D, Fuentes IA, Zilberman JM, Rodriguez P, Babinyan KY, Engibaryan AH, Avagyan AM, Minasyan AA, Gevorkyan AT, Carnagarin R, Carrington MJ, Sharman JE, Lee R, Perl S, Niederl E, Malik FT, Choudhury SR, Al Mamun MA, Ishraquzzaman M, Anthony F, Connell K, De Backer TLM, Krzesinski J, Houenassi MD, Houehanou CY, Sokolovic S, Bahtijarevic R, Tiro MB, Mosepele M, Masupe TK, Barroso WS, Gomes MAM, Feitosa ADM, Brandão AA, Miranda RD, Azevedo VMAA, Dias LM, Garcia GDN, Martins IPP, Dzudie A, Kingue S, Djomou FAN, Njume E, Khan N, Lanas FT, Garcia MS, Paccot MF, Torres PI, Li Y, Liu M, Xu L, Li L, Chen X, Deng J, Zhao W, Fu L, Zhou Y, Lopez-Jaramillo P, Otero J, Camacho PA, Accini JL, Sanchez G, Arcos E, M'Buyamba-Kabangu JR, Katamba FK, Ngoyi GN, Buila NM, Bayauli PM, Ellenga Mbolla BF, Bakekolo PR, Kouala Landa CM, Kimbally Kaky GS, Kramoh EK, Ngoran YNK, Olsen MH, Valdez Valoy L, Santillan M, Angel Rafael GM, Peñaherrera CE, Villalba J, Ramirez MI, Arteaga F, Delgado P, Beistline H, Cappuccio FP, Keitley J, Tay T, Goshu DY, Kassie DM, Gebru SA, Pathak A, Denolle T, Tsinamdzgvrishvili B, Trapaidze D, Sturua L, Abesadze T, Grdzelidze N, Grabfelder M, Krämer BK, Schmeider RE, Twumasi-Ankrah B, Tannor EK, Lincoln MD, Deku EM, Wyss Quintana FS, Kenerson J, Jean Baptiste ED, Saintilmond WW, Barrientos AL, Peiger B, Lagos AR, Forgas MA, Lee VWY, Tomlinson BWY, Járai Z, Páll D, More A, Maheshwari A, Verma N, Sharma M, Mukherjee TK, Patil M, Pulikkottil Jose A, More A, Takalkar A, Turana Y, Widyantoro B, Danny SS, Djono S, Handari SD, Tambunan M, Tiksnadi BB, Hermiawaty E, Tavassoli E, Zolfaghari M, Dolan E, O'Brien E, Borghi C, Ferri C, Torlasco C, Parati G, Nwokocha CR, Nwokocha MI, Ogola EN, Gitura BM, Barasa AL, Barasa FA, Wairagu AW, Nalwa WZ, Najem RN, Abu Alfa AK, Fageh HA, Msalam OM, Derbi HA, Bettamar KA, Zakauskiene U, Vickiene A, Calmes J, Alkerwi A, Gantenbein M, Ndhlovu HLL, Masiye JK, Chirwa ML, Nyirenda NM, Dhlamini TD, Chia YC, Ching SM, Devaraj NK, Ouane N, Fane T, Kowlessur S, Ori B, Heecharan J, Alcocer L, Chavez A, Ruiz G, Espinosa C, Gomez-Alvarez E, Neupane D, Bhattarai H, Ranabhat K, Adhikari TB, Koirala S, Toure IA, Soumana KH, Wahab KW, Omotoso AB, Sani MU, Okubadejo NU, Nadar SK, Al-Riyami HA, Ishaq M, Memon F, Sidique S, Choudhry HA, Khan RA, Ayala M, Maidana AJO, Bogado GG, Ona DI, Atilano A, Granada C, Bartolome R, Manese L, Mina A, Dumlao MC, Villaruel MC, Gomez L, Jóźwiak J, Małyszko J, Banach M, Mastej M, de Carvalho Rodrigues MM, Martins LL, Paval A, Dorobantu M, Konradi AO, Chazova IE, Rotar O, Spoares MC, Viegas D, Almustafa BA, Alshurafa SA, Brady A, Bovet P, Viswanathan B, Oladapo OO, Russell JW, Brguljan-Hitij J, Bozic N, Knez J, Dolenc P, Hassan MM, Woodiwiss AJ, Myburgh C, Vally M, Ruilope LM, Molinero A, Rodilla E, Gijón-Conde T, Beheiry HM, Ali IA, Osman AAA, Fahal NAW, Osman HA, Altahir F, Persson M, Wuerzner G, Burkard T, Wang TD, Lin HJ, Pan HY, Chen WJ, Lin E, Mondo CK, Ingabire PM, Khomazyuk TT, Krotova VV, Negresku E, Evstigneeva O, Bazargani NN, Agrawal A, Bin Belaila BA, Suhail AM, Muhammed KO, Shuri HH, Wainford RD, Levy PD, Boggia JJ, Garré LL, Hernandez-Hernandez R, Octavio-Seijas JA, Lopez-Rivera JA, Morr I, Duin A, Huynh MV, Cao ST, Nguyen VL, To M, Phan HN, Cockroft J, McDonnell B, Goma FM, Syatalimi C, Chifamba J, Gwini R, Tiburcio OV, Xia X.

Author information

1
Imperial Clinical Trials Unit, Imperial College London, London, UK.
2
Department of Primary Care and Public Health, Imperial College London, London, UK.
3
Department of Medicine, University of Melbourne, Austin Health, Melbourne, VIC, Australia.
4
Adventist University of the Philippines College of Medicine, Silang, Cavite, Philippines.
5
Federation University Australia, Ballarat, VIC, Australia.
6
Department of Physiology, Eduardo Mondlane University, Maputo, Mozambique.
7
Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
8
Hypertension in Africa Research Team; South African Medical Research Council, North-West University, Potchefstroom, South Africa.
9
Department of History of Medicine, Lund University, Skane University Hospital, Malmo, Sweden.
10
Department of Research and Policy, Public Health Foundation of India, Haryana, India.
11
Department of Pharmacology and Physiology, Hospital Hospital Universitario Fundación Favaloro, Buenos Aires, Argentina.
12
Dobney Hypertension Centre, Royal Perth Hospital Campus, University of Western Australia, Perth, WA, Australia.
13
Faculty of Biology, Medicine and Health, Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.
14
Institute of Cardiovascular and Medical Sciences, Cardiovascular Research Centre, Glasgow, Scotland.
15
Department of Hypertension, Rujin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
16
State University of New York, Downstate Medical Centre, New York, USA.

Abstract

AIMS:

Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries.

METHODS AND RESULTS:

Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension.

CONCLUSION:

May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.

KEYWORDS:

Blood pressure; Control; Global; Hypertension; Screening; Treatment

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center